# PDE Inhibitors in DMD Study (Acute Dosing Study)

> **NCT01580501** · PHASE1 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 12 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** Tadalafil and Sildenafil

## Key facts

- **NCT ID:** NCT01580501
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-03
- **Final completion:** —
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2014-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580501, "PDE Inhibitors in DMD Study (Acute Dosing Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01580501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*